apr 15, 2009 - Pfizer acquires global licensing rights (ex-Israel) from Protalix for its late stage Gaucher asset Protalix's ProCellEx technology uses plant-based cells for drug production, reducing contamination risk

Added to timeline:

4 Oct 2017

0

0

609

New timeline

All

Date: